研究成果 (3)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/1

A C D I O P Q S T Z 全部

Intermittent versus continuous erlotinib with concomitant modified ‘XELOX’ (q3W) in first-line treatment of metastatic colorectal cancer (mCRC)
MA Buig Yue Brigette, CHAN Lam Stephen, HO Ming Wing, POON Annette Ngar, HUI Pun Edwin, DATTATRAY R D, WONG S C, CHAN Anthony Tak Cheung ( 2010 )
35th ESMO Congress
Invited conference paper presented and published in conference proceedings
Integrative epigenetics identifies a novel tumor suppressor RNF180, silenced by CpG methylation in multiple cancers, targeting multiple oncoproteins for degradation
LI Lili, NG Ka Man, ZHANG Y, FAN Yichao, SHU, Xingsheng, SU X, LEUNG S F, CHAN Anthony Tak Cheung, TAO Qian ( 2010 )
The 2nd International Cancer Epigenetics Symposium
Invited conference paper presented and published in conference proceedings
Identification of a novel pro-apoptotic 1p36.3 tumor suppressor inhibiting multiple oncogenic signalings and frequently silenced in carcinomas
GENG Hua, POON Fan Fong, PENG J, SOO L, WU W, CHENG Y, SHU Xingsheng, YING JIANMING, WU L, KO B C, YU J, GOH H K, SUNG J J, CHAN Anthony Tak Cheung, TAO Qian ( 2010 )
The 15th Annual Scientific Symposium of Hong Kong Cancer Institute - 5th Sino-US Conference: Personalized Medicine in Cancer Therapy
Invited conference paper presented and published in conference proceedings

10 | 25 | 50 | 100

1/1

分享連結